iShares Dow Jones US Medical Dev. Stock Price, News & Analysis (BMV:IHI)

iShares Dow Jones US Medical Dev. trades on the BMV under the ticker symbol "IHI."

iShares Dow Jones US Medical Dev. announced a -- dividend on Tuesday, September 24th. Shareholders of record on Wednesday, September 25th will be given a dividend of $0.1886 per share on Monday, September 30th. This represents a yield of 0.3%. The ex-dividend date of this dividend is Tuesday, September 24th. View iShares Dow Jones US Medical Dev.'s Dividend History.

Media coverage about IHI stock has been trending neutral recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. iShares Dow Jones US Medical Dev. earned a news sentiment score of 0.2 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days. View News Stories for iShares Dow Jones US Medical Dev..

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Dow Jones US Medical Dev. investors own include Shopify (SHOP), Adobe (ADBE), Cyberark Software (CYBR), iShares 20+ Year Treasury Bond ETF (TLT), salesforce.com (CRM), Veeva Systems (VEEV), Coupa Software (COUP), IQIYI (IQ), NVIDIA (NVDA) and Okta (OKTA).

Shares of IHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.